{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:05:19Z","timestamp":1789452319127,"version":"build-2803163510"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      The growing threat of multidrug-resistant (MDR)\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      (\n                      <jats:italic>P. aeruginosa)<\/jats:italic>\n                      has created an urgent need for novel therapeutic strategies to combat refractory lung infections. The limited efficacy of traditional antibiotics against this pathogen highlights the necessity of developing alternative treatments. Our study aims to develop a broad-spectrum bacteriophage cocktail suitable for nebulization and to evaluate its antibacterial efficacy and safety in respiratory infections caused by MDR\n                      <jats:italic>P. aeruginosa<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We constructed a seven-phage cocktail by selecting phages with complementary host ranges, strong lytic activity, and different receptor targets. The antimicrobial and anti-biofilm activity of the cocktail was assessed\n                      <jats:italic>in vitro<\/jats:italic>\n                      against clinical MDR\n                      <jats:italic>P. aeruginosa<\/jats:italic>\n                      isolates. The therapeutic efficacy and safety were further investigated in a murine pneumonia model following nebulized administration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The phage cocktail demonstrated lytic activity against nearly 90% of 152 clinical\n                      <jats:italic>P. aeruginosa i<\/jats:italic>\n                      solates, indicating broad coverage. Compared to single phages or antibiotics, the cocktail showed superior activity in both inhibiting and disrupting biofilms. In the murine pneumonia model, nebulized phage therapy improved survival, reduced bacterial burdens in lung and liver, and alleviated infection-related histopathological damage. Safety assessment revealed no obvious hematological, biochemical or histopathological abnormalities in both acute and long-term administration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      High-dose nebulized administration of this phage cocktail reduced bacterial burden and showed favorable tolerability in a murine model of MDR\n                      <jats:italic>P. aeruginosa<\/jats:italic>\n                      pneumonia. These findings provide preclinical evidence supporting further evaluation of inhaled phage cocktails as a potential therapeutic strategy for refractory respiratory infections.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1912918","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:36:21Z","timestamp":1789450581000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A broad-host-range inhalable phage cocktail for treatment of multidrug-resistant Pseudomonas aeruginosa pulmonary infections"],"prefix":"10.3389","volume":"16","author":[{"given":"Zixun","family":"Lin","sequence":"first","affiliation":[{"name":"National Clinical Research Centre for Infectious Diseases, The Third People\u2019s Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Southern University of Science and Technology","place":["Shenzhen, China"]},{"name":"School of Medicine, Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofu","family":"Wan","sequence":"additional","affiliation":[{"name":"National Clinical Research Centre for Infectious Diseases, The Third People\u2019s Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangke","family":"Duan","sequence":"additional","affiliation":[{"name":"National Clinical Research Centre for Infectious Diseases, The Third People\u2019s Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Southern University of Science and Technology","place":["Shenzhen, China"]},{"name":"PhageNovoTech Co., Ltd.","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Liang","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Institute of Comparative Medicine, Yangzhou University","place":["Yangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Institute of Comparative Medicine, Yangzhou University","place":["Yangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuxin","family":"Qu","sequence":"additional","affiliation":[{"name":"National Clinical Research Centre for Infectious Diseases, The Third People\u2019s Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuandong","family":"Zhou","sequence":"additional","affiliation":[{"name":"National Clinical Research Centre for Infectious Diseases, The Third People\u2019s Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ming","sequence":"additional","affiliation":[{"name":"National Clinical Research Centre for Infectious Diseases, The Third People\u2019s Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Zeng","sequence":"additional","affiliation":[{"name":"National Clinical Research Centre for Infectious Diseases, The Third People\u2019s Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhong","family":"Han","sequence":"additional","affiliation":[{"name":"National Clinical Research Centre for Infectious Diseases, The Third People\u2019s Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Southern University of Science and Technology","place":["Shenzhen, China"]},{"name":"School of Medicine, Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijia","family":"Ling","sequence":"additional","affiliation":[{"name":"National Clinical Research Centre for Infectious Diseases, The Third People\u2019s Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenheng","family":"Gan","sequence":"additional","affiliation":[{"name":"National Clinical Research Centre for Infectious Diseases, The Third People\u2019s Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yang","sequence":"additional","affiliation":[{"name":"National Clinical Research Centre for Infectious Diseases, The Third People\u2019s Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Institute of Comparative Medicine, Yangzhou University","place":["Yangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhou","family":"Lu","sequence":"additional","affiliation":[{"name":"National Clinical Research Centre for Infectious Diseases, The Third People\u2019s Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Southern University of Science and Technology","place":["Shenzhen, China"]},{"name":"School of Medicine, Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Shen","sequence":"additional","affiliation":[{"name":"National Clinical Research Centre for Infectious Diseases, The Third People\u2019s Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1111\/ajt.15503","article-title":"Early clinical experience of bacteriophage therapy in 3 lung transplant recipients","volume":"19","author":"Aslam","year":"2019","journal-title":"Am. J. Transplant."},{"key":"B2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ejpb.2018.01.010","article-title":"Nebulization effects on structural stability of bacteriophage PEV 44","volume":"125","author":"Astudillo","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ymben.2024.02.004","article-title":"Genome-scale and pathway engineering for the sustainable aviation fuel precursor isoprenol production in Pseudomonas putida","volume":"82","author":"Banerjee","year":"2024","journal-title":"Metab. Eng."},{"key":"B4","doi-asserted-by":"publisher","first-page":"9047","DOI":"10.1007\/s00253-021-11695-z","article-title":"Phage therapeutics: from promises to practices and prospectives","volume":"105","author":"Bhargava","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2024.127662","article-title":"Phage formulations and delivery strategies: Unleashing the potential against antibiotic-resistant bacteria","volume":"282","author":"Bolsan","year":"2024","journal-title":"Microbiol. Res."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2104592118","article-title":"Coevolutionary phage training leads to greater bacterial suppression and delays the evolution of phage resistance","volume":"118","author":"Borin","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btac776","article-title":"Pharokka: a fast scalable bacteriophage annotation tool","volume":"39","author":"Bouras","year":"2023","journal-title":"Bioinformatics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/s41591-025-03678-8","article-title":"Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis","volume":"31","author":"Chan","year":"2025","journal-title":"Nat. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.5582\/bst.2022.01147","article-title":"Bacteriophage therapy for empyema caused by carbapenem-resistant Pseudomonas aeruginosa","volume":"16","author":"Chen","year":"2022","journal-title":"Biosci. Trends"},{"key":"B11","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3760\/cma.j.cn311365-20230418-00120","article-title":"Chinese expert recommendation on phage therapy in the clinical practice","volume":"41","year":"2023","journal-title":"Chin. J. Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.addr.2014.11.017","article-title":"Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients","volume":"85","author":"Ciofu","year":"2015","journal-title":"Adv. Drug Delivery Rev."},{"key":"B13","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing, M100","year":"2023"},{"key":"B14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.tim.2018.08.006","article-title":"Molecular and evolutionary determinants of bacteriophage host range","volume":"27","author":"De Jonge","year":"2019","journal-title":"Trends Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13578-021-00655-9","article-title":"rpoS-mutation variants are selected in Pseudomonas aeruginosa biofilms under imipenem pressure","volume":"11","author":"Duan","year":"2021","journal-title":"Cell Biosci."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02914-22","article-title":"Fitness trade-offs in phage cocktail-resistant Salmonella enterica serovar Enteritidis results in increased antibiotic susceptibility and reduced virulence","volume":"10","author":"Gao","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"B17","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","article-title":"Grading and staging systems for inflammation and fibrosis in chronic liver diseases","volume":"47","author":"Goodman","year":"2007","journal-title":"J. Hepatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"W484","DOI":"10.1093\/nar\/gkad326","article-title":"Proksee: in-depth characterization and visualization of bacterial genomes","volume":"51","author":"Grant","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156663","article-title":"Luteolin inhibits inflammation and M1 macrophage polarization in the treatment of Pseudomonas aeruginosa-induced acute pneumonia through suppressing EGFR\/PI3K\/AKT\/NF-\u03baB and EGFR\/ERK\/AP-1 signaling pathways","volume":"141","author":"Gu","year":"2025","journal-title":"Phytomedicine"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108782","article-title":"Pseudomonas aeruginosa aggregates in cystic fibrosis sputum produce exopolysaccharides that likely impede current therapies","volume":"34","author":"Jennings","year":"2021","journal-title":"Cell Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.12688\/wellcomeopenres.14826.1","article-title":"Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications","volume":"3","author":"Jolley","year":"2018","journal-title":"Wellcome Open Res."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00864-17","article-title":"Psl produced by mucoid Pseudomonas aeruginosa contributes to the establishment of biofilms and immune evasion","volume":"8","author":"Jones","year":"2017","journal-title":"mBio"},{"key":"B23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1208\/s12249-019-1608-4","article-title":"An efficient and cost-effective nose-only inhalational chamber for rodents: Design, optimization and validation","volume":"21","author":"Kaur","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"B24","doi-asserted-by":"publisher","first-page":"9987","DOI":"10.1038\/s41467-024-53994-9","article-title":"A blueprint for broadly effective bacteriophage-antibiotic cocktails against bacterial infections","volume":"15","author":"Kim","year":"2024","journal-title":"Nat. Commun."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3791\/3857","article-title":"Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung","volume":"64","author":"Kirchner","year":"2012","journal-title":"J. Vis. Exp."},{"key":"B26","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s40121-022-00591-2","article-title":"Therapeutic strategies for emerging multidrug-resistant Pseudomonas aeruginosa","volume":"11","author":"Kunz Coyne","year":"2022","journal-title":"Infect. Dis. Ther."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2022.105732","article-title":"Phage resistance-mediated trade-offs with antibiotic resistance in Salmonella Typhimurium","volume":"171","author":"Laure","year":"2022","journal-title":"Microb. Pathog."},{"key":"B28","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s15010-019-01319-0","article-title":"Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient","volume":"47","author":"Law","year":"2019","journal-title":"Infection"},{"key":"B29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ijid.2023.11.023","article-title":"The global epidemiology of ventilator-associated pneumonia caused by multi-drug resistant Pseudomonas aeruginosa: A systematic review and meta-analysis","volume":"139","author":"Li","year":"2024","journal-title":"Int. J. Infect. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/s0954-6111(03)00231-2","article-title":"Lower respiratory tract infections in chronic obstructive pulmonary disease outpatients with tracheostomy and persistent colonization by P. aeruginosa","volume":"97","author":"Lusuardi","year":"2003","journal-title":"Respir. Med."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/s2666-5247(23)00097-6","article-title":"Biofilm formation and virulence potential of carbapenem-resistant Pseudomonas aeruginosa","volume":"4","author":"Ma","year":"2023","journal-title":"Lancet Microbe"},{"key":"B32","doi-asserted-by":"publisher","first-page":"310","DOI":"10.25259\/ijn_282_23","article-title":"Histopathological and immunohistochemical study of acute tubular injury in native kidney biopsy","volume":"34","author":"Mahajan","year":"2024","journal-title":"Indian J. Nephrol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00138-18","article-title":"Cystic fibrosis and Pseudomonas aeruginosa: the host-microbe interface","volume":"32","author":"Malhotra","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1165\/rcmb.2009-0210ST","article-title":"An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals","volume":"44","author":"Matute-Bello","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"10219","DOI":"10.1038\/s41467-025-65014-5","article-title":"Directed evolution of phages in biofilms enhances Pseudomonas aeruginosa control through improved lipopolysaccharide recognition","volume":"16","author":"Meneses","year":"2025","journal-title":"Nat. Commun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"i142","DOI":"10.1093\/bioinformatics\/bty266","article-title":"Versatile genome assembly evaluation with QUAST-LG","volume":"34","author":"Mikheenko","year":"2018","journal-title":"Bioinformatics"},{"key":"B37","doi-asserted-by":"publisher","first-page":"220121","DOI":"10.1183\/16000617.0121-2022","article-title":"Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations","volume":"31","author":"Mitropoulou","year":"2022","journal-title":"Eur. Respir. Rev."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.625597","article-title":"Immune responses to Pseudomonas aeruginosa biofilm infections","volume":"12","author":"Moser","year":"2021","journal-title":"Front. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"6191","DOI":"10.1128\/jb.01651-09","article-title":"Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis","volume":"192","author":"Mulcahy","year":"2010","journal-title":"J. Bacteriol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3390\/idr16060092","article-title":"Advancing phage therapy: A comprehensive review of the safety, efficacy, and future prospects for the targeted treatment of bacterial infections","volume":"16","author":"Palma","year":"2024","journal-title":"Infect. Dis. Rep."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/toxics13040303","article-title":"Deciphering multidrug-resistant Pseudomonas aeruginosa: Mechanistic insights and environmental risks","volume":"13","author":"Pei","year":"2025","journal-title":"Toxics"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/cpbi.102","article-title":"Using SPAdes de novo assembler","volume":"70","author":"Prjibelski","year":"2020","journal-title":"Curr. Protoc. Bioinf."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1080\/08927014.2011.631169","article-title":"Characterization of induced Staphylococcus aureus bacteriophage SAP-26 and its anti-biofilm activity with rifampicin","volume":"27","author":"Rahman","year":"2011","journal-title":"Biofouling"},{"key":"B44","doi-asserted-by":"publisher","first-page":"9529","DOI":"10.1007\/s00210-025-03971-w","article-title":"Different aspects of Pseudomonas aeruginosa biofilm: an in-depth analysis from formation to detection","volume":"398","author":"Rawat","year":"2025","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s40265-021-01635-6","article-title":"The epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa infections: An update","volume":"81","author":"Reynolds","year":"2021","journal-title":"Drugs"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1093\/bioinformatics\/btu153","article-title":"Prokka: rapid prokaryotic genome annotation","volume":"30","author":"Seemann","year":"2014","journal-title":"Bioinformatics"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1297528","article-title":"Distribution and antimicrobial resistance analysis of gram-negative bacilli isolated from a tertiary hospital in Central China: a 10-year retrospective study from 2012 to 2021","volume":"14","author":"Shi","year":"2023","journal-title":"Front. Microbiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2022.11.017","article-title":"Phage therapy: From biological mechanisms to future directions","volume":"186","author":"Strathdee","year":"2023","journal-title":"Cell."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.631585","article-title":"Clinical experience of personalized phage therapy against carbapenem-resistant Acinetobacter baumannii lung infection in a patient with chronic obstructive pulmonary disease","volume":"11","author":"Tan","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/v16071080","article-title":"Phage therapy in a burn patient colonized with extensively drug-resistant Pseudomonas aeruginosa responsible for relapsing ventilator-associated pneumonia and bacteriemia","volume":"16","author":"Teney","year":"2024","journal-title":"Viruses"},{"key":"B51","doi-asserted-by":"publisher","first-page":"11005","DOI":"10.1038\/s41598-026-44002-9","article-title":"Genetic basis of immunity in Indian cattle as revealed by comparative analysis of Bos genome","volume":"16","author":"Thambiraja","year":"2026","journal-title":"Sci. Rep."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/v15020427","article-title":"Development and evaluation of bacteriophage cocktail to eradicate biofilms formed by an extensively drug-resistant (XDR) Pseudomonas aeruginosa","volume":"15","author":"Vashisth","year":"2023","journal-title":"Viruses"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9070371","article-title":"Tackling intrinsic antibiotic resistance in Serratia Marcescens with a combination of ampicillin\/Sulbactam and phage SALSA","volume":"9","author":"Weber","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"20719","DOI":"10.1038\/s41598-025-07820-x","article-title":"Risk factors for multidrug resistant and carbapenem resistant Pseudomonas aeruginosa bloodstream infections among inpatients in Central and East China","volume":"15","author":"Xiao","year":"2025","journal-title":"Sci. Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-1-0716-3798-2_12","article-title":"Visualization of engineered M13 phages bound to bacterial targets by transmission electron microscopy","volume":"2793","author":"Yang","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.682255","article-title":"The efficacy of phage therapy in a murine model of Pseudomonas aeruginosa pneumonia and sepsis","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Microbiol."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s44318-026-00740-0","article-title":"Simultaneous inhibition of bacterial virulence and anti-phage defense systems by synergistic bacteriophage counter-defense proteins","volume":"45","author":"Zhao","year":"2026","journal-title":"EMBO J"},{"key":"B58","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12951-024-02610-5","article-title":"Repair spinal cord injury with a versatile anti-oxidant and neural regenerative nanoplatform","volume":"22","author":"Zhou","year":"2024","journal-title":"J. Nanobiotechnology"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2025.128107","article-title":"Recent advancements in bacterial anti-phage strategies and the underlying mechanisms altering susceptibility to antibiotics","volume":"295","author":"Zou","year":"2025","journal-title":"Microbiol. Res."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1912918\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:36:23Z","timestamp":1789450583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1912918\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":59,"alternative-id":["10.3389\/fcimb.2026.1912918"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1912918","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"1912918"}}